Our mission is to improve the lives of all patients afflicted with cancer. To that end, we develop innovative pathology lab instruments, cytology and tissue-based clinical assays and software solutions that empower anatomical pathologists worldwide.
Roche Tissue Diagnostics is the global leader in solutions for anatomical pathology labs to help prevent and diagnose cancer. We are shaping the future of personalized healthcare with integrated pathology instruments, clinically significant assays and tools that advance diagnostic certainty and optimize medical value. Together with our Roche colleagues and pharma partners, we also develop and commercialize predictive assays that empower pathologists and oncologists to target therapies personalized for each patient.
Our portfolio of VENTANA and BenchMark products offer prompt, precise cytology and tissue-based results so pathologists, physicians and patients can make confident clinical management and treatment decisions. Our histology equipment features next-generation automated H&E slide staining, immunohistochemistry (IHC) and in situ hybridization (ISH) staining platforms; plus, highly sensitive detection kits, probes and clinical testing assays.
The Roche Digital Pathology solution combines innovative hardware and software including the uPath image analysis algorithm suite, to work in concert with the full Roche diagnostics portfolio for an end-to-end solution. Roche is delivering powerful digital pathology solutions that enable better, more personalized healthcare -- now and in the years to come.